Related Experiment Video
Updated: Feb 5, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Dual PAK4-NAMPT Inhibition Impacts Growth and Survival, and Increases Sensitivity to DNA-Damaging Agents in
Na Li1,2, Michael A Lopez1, Maria Linares3
1LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Purpose:
p21-activated kinase 4 (PAK4) plays a significant biological and functional role in a number of malignancies, including multiple myeloma (MM). On the basis of our promising findings in MM, we here characterize PAK4 expression and role in WM cells, as well effect of dual PAK4-NAMPT inhibitor (KPT-9274) against WM cell growth and viability.
Experimental Design:
We have analyzed mRNA and protein expression levels of PAK4 in WM cells, and used loss-of-function approach to investigate its contribution to WM cell viability. We have further tested the in vitro and in vivo effect of KPT-9274 against WM cell growth and viability.
Results:
We report here high-level expression and functional role of PAK4 in WM, as demonstrated by shRNA-mediated knockdown; and significant impact of KPT-9274 on WM cell growth and viability. The growth inhibitory effect of KPT-9274 was associated with decreased PAK4 expression and NAMPT activity, as well as induction of apoptosis. Interestingly, in WM cell lines treated with KPT-9274, we detected a significant impact on DNA damage and repair genes. Moreover, we observed that apart from inducing DNA damage, KPT-9274 specifically decreased RAD51 and the double-strand break repair by the homologous recombination pathway. As a result, when combined with a DNA alkylating agents bendamustine and melphalan, KPT-9274 provided a synergistic inhibition of cell viability in WM cell lines and primary patient WM cells in vitro and in vivo.
Conclusions:
These results support the clinical investigation of KPT-9274 in combination with DNA-damaging agent for treatment of WM.
Insights
p21-activated kinase 4 (PAK4) is highly expressed in Waldenström's macroglobulinemia (WM) cells. A dual PAK4-NAMPT inhibitor, KPT-9274, effectively reduces WM cell growth and viability by inducing apoptosis and DNA damage.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- p21-activated kinase 4 (PAK4) is implicated in various cancers, including multiple myeloma (MM).
- Understanding PAK4's role in Waldenström's macroglobulinemia (WM) is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate PAK4 expression and function in WM cells.
- To evaluate the efficacy of the dual PAK4-NAMPT inhibitor KPT-9274 against WM cells in vitro and in vivo.
Main Methods:
- Analysis of PAK4 mRNA and protein expression in WM cells.
- Loss-of-function studies using shRNA to assess PAK4's role in WM cell viability.
- In vitro and in vivo testing of KPT-9274 efficacy.
- Assessment of DNA damage and repair pathways following KPT-9274 treatment.
- Combination studies with DNA alkylating agents (bendamustine, melphalan).
Main Results:
- High-level expression and functional significance of PAK4 were confirmed in WM cells.
- KPT-9274 significantly inhibited WM cell growth and viability, decreasing PAK4 expression and NAMPT activity, and inducing apoptosis.
- KPT-9274 treatment impacted DNA damage and repair genes, specifically reducing RAD51 and homologous recombination-mediated double-strand break repair.
- Synergistic inhibition of cell viability was observed when KPT-9274 was combined with bendamustine or melphalan in WM cell lines and primary patient cells.
Conclusions:
- PAK4 plays a critical role in WM pathogenesis.
- KPT-9274 demonstrates significant anti-WM activity, mediated through apoptosis induction and disruption of DNA repair pathways.
- Combination therapy with KPT-9274 and DNA-damaging agents warrants clinical investigation for WM treatment.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Feedback Inhibition
Increasing Function
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Survival Tree
Building a Survival Tree
Constructing a...

